Food and Drug Administration,
Dockets Management Branch, 5630 Fishers Lane - Room 1061- HFA-305, Rockville,
MD, 20852; 301-827-6860; Fax 301-827-6870 [E-mail
Us]
DOCKETS ENTERED on December 19, 2000 TABLE OF CONTENTS Hyper links are part of the Docket title - not all dockets/documents are linked. NOTE: Documents received by the Dockets Management Branch "MAY" be posted on the Internet. PLEASE DO NOT include personal identifying information, i.e. date of birth, social security number, etc., in your correspondence. |
91N-0101 Antioxidant Vitamins & Cancer,Hlth. Claims & Label Statement * 97N-0314 Prescription Drug Products; Levothyroxine Sodium * 98P-1194 Withdrawal NADA Approval for Posilac - rBGH * 00N-1409 Revision of the Identification of the Ionotophoresis * 00P-1363 To Amend 21 CFR 165.110 to include a Standard of Identity * 00P-1675 Triage B-Type Natriuetic Peptide (BNP) Test (K003475) * 00P-1676 Electrode Lead Wires and Patient Cables * |
SUP 5 Emord & Associates P C Vol#: 46
97N-0314 Prescription Drug Products; Levothyroxine Sodium
SUP 5 Knoll Pharmaceutical Company Vol#: 8
98P-1194 Withdrawal NADA Approval for Posilac - rBGH
C 804 Inez P Petersen Vol#: 36
C 805 Shauna Matetich Vol#: 36
99N-4282 Biotechnology in the Year 2000 and Beyond; Public Meetings
C 16826 Form letter count 11 Vol#: 486
00N-1409 Revision of the Identification of the Ionotophoresis
C 4 Birch Point Medical Inc Vol#: 2
C 6 Life Tech International Inc Vol#: 1
C 7 Dynatronics Corporation Vol#: 1
00P-1363 To Amend 21 CFR 165.110 to include a Standard of Identity
LET 1 HFS-800 to Iceberg Industries Corp (Cana Vol#: 1
00P-1675 Triage B-Type Natriuetic Peptide (BNP) Test (K003475)
CCP 1 Biosite Diagnostics, Incorporated Vol#: 1
00P-1676 Electrode Lead Wires and Patient Cables